Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 46 Records) |
| Query Trace: Melanoma and HLA-B[original query] |
|---|
| Whole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanoma. Oncotarget 2015 Jan 6 (2): 1115-27. Wong Stephen Q, Behren Andreas, Mar Victoria J, Woods Katherine, Li Jason, Martin Claire, Sheppard Karen E, Wolfe Rory, Kelly John, Cebon Jonathan, Dobrovic Alexander, McArthur Grant |
| Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-a but Not Observation in Intermediate Risk Melanoma Patients. PloS one 2015 10 (7): e0132745. Tarhini Ahmad A, Lin Yan, Zahoor Haris, Shuai Yongli, Butterfield Lisa H, Ringquist Steven, Gogas Helen, Sander Cindy, Lee Sandra, Agarwala Sanjiv S, Kirwood John |
| MHC class I chain-related gene a diversity in patients with cutaneous malignant melanoma from southeastern Spain. Disease markers 2015 2015 831864. Campillo José Antonio, López-Hernández Ruth, Martínez-Banaclocha Helios, Bolarín José Miguel, Gimeno Lourdes, Mrowiec Anna, López Manuela, Las Heras Beatriz, Minguela Alfredo, Moya-Quiles Maria Rosa, Legáz Isabel, Frías-Iniesta José Francisco, García-Alonso Ana María, Álvarez-López María Rocío, Martínez-Escribano Jorge Antonio, Muro Manu |
| A systematic investigation of the contribution of genetic variation within the MHC region to HPV seropositivity. Human molecular genetics 2015 May 24 (9): 2681-8. Chen Dan, Gaborieau Valérie, Zhao Yao, Chabrier Amélie, Wang Huibo, Waterboer Tim, Zaridze David, Lissowska Jolanta, Rudnai Peter, Fabianova Eleonora, Bencko Vladimir, Janout Vladimir, Foretova Lenka, Mates Ioan Nicolae, Szeszenia-Dabrowska Neonila, Boffetta Paolo, Pawlita Michael, Lathrop Mark, Gyllensten Ulf, Brennan Paul, McKay James |
| Pyrexia in dabrafenib-treated melanoma patients is not associated with common genetic variation or HLA polymorphisms. Pharmacogenomics 2016 Apr 17 (5): 459-62. Kulkarni Diptee, Song Kijoung, Briley Linda, King Karen, Dabrowski Christine, Mookerjee Bijoyesh, Legos Jeff, Spraggs Col |
| Genetic risk analysis of a patient with fulminant autoimmune type 1 diabetes mellitus secondary to combination ipilimumab and nivolumab immunotherapy. Journal for immunotherapy of cancer 2016 12 4 89. Lowe Jared R, Perry Daniel J, Salama April K S, Mathews Clayton E, Moss Larry G, Hanks Brent |
| HLA-DRB1 Alleles as Genetic Risk Factors for the Development of Anti-MDA5 Antibodies in Patients with Dermatomyositis. The Journal of rheumatology 2017 Sep 44 (9): 1389-1393. Chen Zhiyong, Wang Yan, Kuwana Masataka, Xu Xue, Hu Wei, Feng Xuebing, Wang Hong, Kimura Akinori, Sun Lingy |
| Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy. Science (New York, N.Y.) 2017 12 359 (6375): 582-587. Chowell Diego, Morris Luc G T, Grigg Claud M, Weber Jeffrey K, Samstein Robert M, Makarov Vladimir, Kuo Fengshen, Kendall Sviatoslav M, Requena David, Riaz Nadeem, Greenbaum Benjamin, Carroll James, Garon Edward, Hyman David M, Zehir Ahmet, Solit David, Berger Michael, Zhou Ruhong, Rizvi Naiyer A, Chan Timothy |
| Genetic association of HLA-DRB1 multiple polymorphisms with dermatomyositis in Chinese population. HLA 2017 12 90 (6): 354-359. Lin J M, Zhang Y B, Peng Q L, Yang H B, Shi J L, Gu M L, Zhao W M, Wang G |
| Haplotypes of the HLA-G 3' Untranslated Region Respond to Endogenous Factors of HLA-G+ and HLA-G- Cell Lines Differentially. PloS one 2017 12 (1): e0169032. Poras Isabelle, Yaghi Layale, Martelli-Palomino Gustavo, Mendes-Junior Celso T, Muniz Yara Costa Netto, Cagnin Natalia F, Sgorla de Almeida Bibiana, Castelli Erick C, Carosella Edgardo D, Donadi Eduardo A, Moreau Philip |
| The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression. Archivum immunologiae et therapiae experimentalis 2017 Jan . Kandilarova Snezhina Mihailova, Paschen Annette, Mihaylova Anastassia, Ivanova Milena, Schadendorf Dirk, Naumova Elissave |
| The genetic diversity within the 1.4?kb HLA-G 5' upstream regulatory region moderately impacts on cellular microenvironment responses. Scientific reports 2018 4 8 (1): 5652. Dias Fabrício C, Bertol Bruna C, Poras Isabelle, Souto Bruno M, Mendes-Junior Celso T, Castelli Erick C, Gineau Laure, Sabbagh Audrey, Rouas-Freiss Nathalie, Carosella Edgardo D, Donadi Eduardo A, Moreau Philip |
| Quantitative Analysis of Immune Infiltrates in Primary Melanoma. Cancer immunology research 2018 2 6 (4): 481-493. Gartrell Robyn D, Marks Douglas K, Hart Thomas D, Li Gen, Davari Danielle R, Wu Alan, Blake Zoë, Lu Yan, Askin Kayleigh N, Monod Anthea, Esancy Camden L, Stack Edward C, Jia Dan Tong, Armenta Paul M, Fu Yichun, Izaki Daisuke, Taback Bret, Rabadan Raul, Kaufman Howard L, Drake Charles G, Horst Basil A, Saenger Yvonne |
| Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors. European journal of cancer (Oxford, England : 1990) 2018 12 107 8-14. Hasan Ali Omar, Berner Fiamma, Bomze David, Fässler Mirjam, Diem Stefan, Cozzio Antonio, Jörger Markus, Früh Martin, Driessen Christoph, Lenz Tobias L, Flatz Luk |
| Do GNAQ and GNA11 Differentially Affect Inflammation and HLA Expression in Uveal Melanoma? Cancers 2019 8 11 (8): . van Weeghel Christiaan, Wierenga Annemijn P A, Versluis Mieke, van Hall Thorbald, van der Velden Pieter A, Kroes Wilma G M, Pfeffer Ulrich, Luyten Gregorius P M, Jager Martine |
| Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets. Nature communications 2019 7 10 (1): 3163. Newell Felicity, Kong Yan, Wilmott James S, Johansson Peter A, Ferguson Peter M, Cui Chuanliang, Li Zhongwu, Kazakoff Stephen H, Burke Hazel, Dodds Tristan J, Patch Ann-Marie, Nones Katia, Tembe Varsha, Shang Ping, van der Weyden Louise, Wong Kim, Holmes Oliver, Lo Serigne, Leonard Conrad, Wood Scott, Xu Qinying, Rawson Robert V, Mukhopadhyay Pamela, Dummer Reinhard, Levesque Mitchell P, Jönsson Göran, Wang Xuan, Yeh Iwei, Wu Hong, Joseph Nancy, Bastian Boris C, Long Georgina V, Spillane Andrew J, Shannon Kerwin F, Thompson John F, Saw Robyn P M, Adams David J, Si Lu, Pearson John V, Hayward Nicholas K, Waddell Nicola, Mann Graham J, Guo Jun, Scolyer Richard |
| Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma. Genome medicine 2019 5 11 (1): 28. Löffler Markus W, Mohr Christopher, Bichmann Leon, Freudenmann Lena Katharina, Walzer Mathias, Schroeder Christopher M, Trautwein Nico, Hilke Franz J, Zinser Raphael S, Mühlenbruch Lena, Kowalewski Daniel J, Schuster Heiko, Sturm Marc, Matthes Jakob, Riess Olaf, Czemmel Stefan, Nahnsen Sven, Königsrainer Ingmar, Thiel Karolin, Nadalin Silvio, Beckert Stefan, Bösmüller Hans, Fend Falko, Velic Ana, Ma?ek Boris, Haen Sebastian P, Buonaguro Luigi, Kohlbacher Oliver, Stevanovi? Stefan, Königsrainer Alfred, , Rammensee Hans-Geo |
| HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients. Annals of oncology : official journal of the European Society for Medical Oncology 2020 Apr . Shim J H, Kim H S, Cha H, Kim S, Kim T M, Anagnostou V, Choi Y-L, Jung H A, Sun J-M, Ahn J S, Ahn M-J, Park K, Park W-Y, Lee S |
| Human leucocyte antigen DR15, a possible predictive marker for immune checkpoint inhibitor-induced secondary adrenal insufficiency. European journal of cancer (Oxford, England : 1990) 2020 4 130 198-203. Yano Seiichi, Ashida Kenji, Sakamoto Ryuichi, Sakaguchi Chihiro, Ogata Masatoshi, Maruyama Kengo, Sakamoto Shohei, Ikeda Munehiko, Ohe Kenji, Akasu Shoko, Iwata Shimpei, Wada Nobuhiko, Matsuda Yayoi, Nakanishi Yoichi, Nomura Masatoshi, Ogawa Yoshihi |
| Computing Skin Cutaneous Melanoma Outcome From the HLA-Alleles and Clinical Characteristics. Frontiers in genetics 2020 4 11 221. Dhall Anjali, Patiyal Sumeet, Kaur Harpreet, Bhalla Sherry, Arora Chakit, Raghava Gajendra P |
| Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma. The New England journal of medicine 2021 9 385 (13): 1196-1206. Nathan Paul, Hassel Jessica C, Rutkowski Piotr, Baurain Jean-Francois, Butler Marcus O, Schlaak Max, Sullivan Ryan J, Ochsenreither Sebastian, Dummer Reinhard, Kirkwood John M, Joshua Anthony M, Sacco Joseph J, Shoushtari Alexander N, Orloff Marlana, Piulats Josep M, Milhem Mohammed, Salama April K S, Curti Brendan, Demidov Lev, Gastaud Lauris, Mauch Cornelia, Yushak Melinda, Carvajal Richard D, Hamid Omid, Abdullah Shaad E, Holland Chris, Goodall Howard, Piperno-Neumann Sophie, |
| Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients. Journal of cancer research and clinical oncology 2021 12 148 (3): 647-656. Purde Mette-Triin, Niederer Rebekka, Wagner Nikolaus B, Diem Stefan, Berner Fiamma, Hasan Ali Omar, Hillmann Dorothea, Bergamin Irina, Joerger Markus, Risch Martin, Niederhauser Christoph, Lenz Tobias L, Früh Martin, Risch Lorenz, Semela David, Flatz Luk |
| HLA-DRB1?16:01 and HLA-DQB1?05:02 Alleles Influence the Susceptibility and Progression of Cutaneous Malignant Melanoma. Journal of oncology 2021 2021 3801143. Wang Xu, Almazan Francisco, Montoyo-Pujol Yoel Genaro, Martin-Casares Antonia, Martin Aurelio, Cabrera Teresa, López-Nevot Miguel Ang |
| Human leukocyte antigen Class II alleles associated with acral lentiginous melanoma in Mexican Mestizo patients: A case-control study. Indian journal of dermatology, venereology and leprology 2021 Dec 1-7. Roldan-Marin Rodrigo, Rangel-Gamboa Lucia, Vega-Memije María E, Hernández-Doño Susana, Ruiz-Gómez Daniela, Granados Jul |
| HLA class II immunogenic mutation burden predicts response to immune checkpoint blockade. Annals of oncology : official journal of the European Society for Medical Oncology 2022 3 33 (7): 728-738. Shao X M, Huang J, Niknafs N, Balan A, Cherry C, White J, Velculescu V E, Anagnostou V, Karchin |
| Insignificant effects of loss of heterozygosity in HLA in the efficacy of immune checkpoint blockade treatment. Genes & genomics 2022 2 44 (4): 509-515. Yang Yohan, Kim Eunyoung, Kim Sangw |
| Analysis of Human Leukocyte Antigen DR Alleles, Immune-Related Adverse Events, and Survival Associated With Immune Checkpoint Inhibitor Use Among Patients With Advanced Malignant Melanoma. JAMA network open 2022 12 5 (12): e2246400. Akturk Halis Kaan, Couts Kasey L, Baschal Erin E, Karakus Kagan E, Van Gulick Robert J, Turner Jacqueline A, Pyle Laura, Robinson William A, Michels Aaron |
| Pervasiveness of HLA allele-specific expression loss across tumor types. Genome medicine 2023 2 15 (1): 8. Filip Ioan, Wang Anqi, Kravets Oleksandr, Orenbuch Rose, Zhao Junfei, Perea-Chamblee Tomin E, Manji Gulam A, López de Maturana Evangelina, Malats Núria, Olive Kenneth P, Rabadan Ra |
| Driver mutations in GNAQ and GNA11 genes as potential targets for precision immunotherapy in uveal melanoma patients. Oncoimmunology 2023 12 12 (1): 2261278. Sandra García-Mulero, Roberto Fornelino, Marco Punta, Stefano Lise, Mar Varela, Luis P Del Carpio, Rafael Moreno, Marcel Costa-García, Dietmar Rieder, Zlatko Trajanoski, Alena Gros, Ramón Alemany, Josep María Piulats, Rebeca Sanz-Pamplo |
| Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A?02-eligible patients. Molecular therapy. Methods & clinical development 2024 6 32 (2): 101265. Tianjiao Wang, Jean-Marc Navenot, Stavros Rafail, Cynthia Kurtis, Mark Carroll, Marian Van Kerckhoven, Sofie Van Rossom, Kelly Schats, Konstantinos Avraam, Robyn Broad, Karen Howe, Ashley Liddle, Amber Clayton, Ruoxi Wang, Laura Quinn, Joseph P Sanderson, Cheryl McAlpine, Carly Carozza, Eric Pimpinella, Susan Hsu, Francine Brophy, Erica Elefant, Paige Bayer, Dennis Williams, Marcus O Butler, Jeffrey M Clarke, Justin F Gainor, Ramaswamy Govindan, Victor Moreno, Melissa Johnson, Janet Tu, David S Hong, George R Blumensche |
- Page last reviewed:Feb 1, 2024
- Content source: